| meta-analysis | Q815382 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1008593369 |
| P356 | DOI | 10.1007/S10545-010-9235-Y |
| P698 | PubMed publication ID | 21069462 |
| P2093 | author name string | Derrick Bennett | |
| Robert Clarke | |||
| Sarah Lewington | |||
| Jim Halsey | |||
| P2860 | cites work | Folic Acid for the Prevention of Colorectal Adenomas | Q22252994 |
| Folic acid and risk of prostate cancer: results from a randomized clinical trial | Q24656971 | ||
| Homocysteine lowering with folic acid and B vitamins in vascular disease | Q28301516 | ||
| Homocysteine lowering and cardiovascular events after acute myocardial infarction | Q28301525 | ||
| Epidemiologic studies of folate and colorectal neoplasia: a review | Q33960655 | ||
| Efficacy of folic acid supplementation in stroke prevention: a meta-analysis | Q34004505 | ||
| Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals | Q34142959 | ||
| Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials | Q34457645 | ||
| Vascular outcome in patients with homocystinuria due to cystathionine beta-synthase deficiency treated chronically: a multicenter observational study | Q34519846 | ||
| The identification of homocystine in the urine | Q34540307 | ||
| HOMOCYSTINURIA: AN ENZYMATIC DEFECT. | Q34540753 | ||
| Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial | Q34544977 | ||
| Will mandatory folic acid fortification prevent or promote cancer? | Q34552492 | ||
| Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial | Q34582863 | ||
| Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial | Q34591566 | ||
| VITATOPS, the VITAmins TO prevent stroke trial: rationale and design of a randomised trial of B-vitamin therapy in patients with recent transient ischaemic attack or stroke (NCT00097669) (ISRCTN74743444). | Q34595593 | ||
| Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial | Q34595749 | ||
| A temporal association between folic acid fortification and an increase in colorectal cancer rates may be illuminating important biological principles: a hypothesis | Q34649705 | ||
| The natural history of homocystinuria due to cystathionine beta-synthase deficiency. | Q34693096 | ||
| Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis | Q34974714 | ||
| The pathogenesis of coronary artery disease. A possible role for methionine metabolism | Q35200217 | ||
| Homocysteine-lowering trials for prevention of cardiovascular events: a review of the design and power of the large randomized trials | Q36380093 | ||
| The SU.FOL.OM3 Study: a secondary prevention trial testing the impact of supplementation with folate and B-vitamins and/or Omega-3 PUFA on fatal and non fatal cardiovascular events, design, methods and participants characteristics | Q36766522 | ||
| Baseline characteristics of participants in the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial | Q37193413 | ||
| Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial | Q38372427 | ||
| Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. | Q41576959 | ||
| HOMOCYSTINURIA: A NEW INBORN ERROR OF METABOLISM ASSOCIATED WITH MENTAL DEFICIENCY. | Q42162413 | ||
| Plasma folate, vitamin B6, vitamin B12, homocysteine, and risk of breast cancer | Q44346773 | ||
| Improvement in stroke mortality in Canada and the United States, 1990 to 2002. | Q46988604 | ||
| A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes | Q56171250 | ||
| A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease | Q57268055 | ||
| Folate and Risk of Breast Cancer: A Meta-analysis | Q58497175 | ||
| Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials | Q69908517 | ||
| Hyperhomocysteinemia: an independent risk factor for vascular disease | Q70131136 | ||
| Plasma homocysteine and coronary heart disease: systematic review of published epidemiological studies | Q77907689 | ||
| Plasma folate, vitamin B-6, vitamin B-12, and risk of breast cancer in women | Q80836616 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | vascular disease | Q1266890 |
| P304 | page(s) | 83-91 | |
| P577 | publication date | 2010-11-11 | |
| P1433 | published in | Journal of Inherited Metabolic Disease | Q6295359 |
| P1476 | title | Homocysteine and vascular disease: review of published results of the homocysteine-lowering trials | |
| P478 | volume | 34 |
| Q36117465 | A nutrient-dense, high-fiber, fruit-based supplement bar increases HDL cholesterol, particularly large HDL, lowers homocysteine, and raises glutathione in a 2-wk trial. |
| Q40112621 | Adenosine plasma level correlates with homocysteine and uric acid concentrations in patients with coronary artery disease. |
| Q39064336 | Correlations between homocysteine and grey matter volume in patients with Alzheimer's disease |
| Q51366263 | Diets high in palmitic acid (16:0), lauric and myristic acids (12:0 + 14:0), or oleic acid (18:1) do not alter postprandial or fasting plasma homocysteine and inflammatory markers in healthy Malaysian adults. |
| Q38022764 | Folate degradation due to ultraviolet radiation: possible implications for human health and nutrition |
| Q37002528 | Homocysteine lowering by folate-rich diet or pharmacological supplementations in subjects with moderate hyperhomocysteinemia. |
| Q34193816 | Homocysteine, grey matter and cognitive function in adults with cardiovascular disease |
| Q43659465 | Hyperhomocysteinemia is an independent risk factor in young patients with coronary artery disease in southern China |
| Q36073594 | Intake of dietary folate and folic acid in Germany based on different scenarios for food fortification with folic acid |
| Q58362346 | Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017 |
| Q88052571 | Low-dose B vitamins supplementation ameliorates cardiovascular risk: a double-blind randomized controlled trial in healthy Chinese elderly |
| Q38239465 | Mediterranean Diet and Cardiovascular Risk: Beyond Traditional Risk Factors |
| Q36155843 | MicroRNA-130a alleviates human coronary artery endothelial cell injury and inflammatory responses by targeting PTEN via activating PI3K/Akt/eNOS signaling pathway. |
| Q27002630 | Modeling cellular compartmentation in one-carbon metabolism |
| Q35049779 | Molecular mechanisms underlying the potentially adverse effects of folate |
| Q35107877 | Multivitamin-mineral use is associated with reduced risk of cardiovascular disease mortality among women in the United States. |
| Q28076931 | Options for basing Dietary Reference Intakes (DRIs) on chronic disease endpoints: report from a joint US-/Canadian-sponsored working group |
| Q36739703 | Palm tocotrienol-rich fraction improves vascular proatherosclerotic changes in hyperhomocysteinemic rats |
| Q36922230 | Plasma folate, but not homocysteine, is associated with Apolipoprotein A1 levels in a non-fortified population |
| Q28068353 | Potential Links between Impaired One-Carbon Metabolism Due to Polymorphisms, Inadequate B-Vitamin Status, and the Development of Alzheimer's Disease |
| Q34586093 | Protein arginine methylation is more prone to inhibition by S-adenosylhomocysteine than DNA methylation in vascular endothelial cells |
| Q40827043 | Related factors of serum uric acid in patients with primary hypertension and hyperhomocysteinemia |
| Q36196397 | Relation of resistin levels with C-reactve protein, homocysteine and uric acid in smokers and non-smokers |
| Q37623995 | Serum homocysteine levels are decreased in levothyroxine-treated women with autoimmune thyroiditis. |
| Q47246348 | Surrogate disease markers as substitutes for chronic disease outcomes in studies of diet and chronic disease relations |
| Q49141144 | The role of iron, omega-3 Fatty acids, and vitamins in heart failure |
| Q36027291 | Therapeutic potential of folic acid supplementation for cardiovascular disease prevention through homocysteine lowering and blockade in rheumatoid arthritis patients. |
| Q43100173 | Trends in clinical laboratory homocysteine testing from 1997 to 2010: the impact of evidence on clinical practice at a single institution. |
| Q38053468 | Updating the relationship between hyperhomocysteinemia lowering therapy and cardiovascular events |
Search more.